We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
52 hedge funds and large institutions have $20.2M invested in Atossa Therapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,419% more call options, than puts
Call options by funds: $1.38M | Put options by funds: $91K
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
70% more capital invested
Capital invested by funds: $11.9M → $20.2M (+$8.32M)
16% more funds holding
Funds holding: 45 → 52 (+7)
0.02% less ownership
Funds ownership: 0.86% → 0.84% (-0.02%)
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
Holders
52
Holders Change
+7
Holders Change %
+15.56%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
10
Reduced
14
Closed
3
Calls
$1.38M
Puts
$91K
Net Calls
+$1.29M
Net Calls Change
+$576K
Top Buyers
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$245K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$216K |
| 3 |
Renaissance Technologies
New York
|
+$112K |
| 4 |
VF
Virtu Financial
New York
|
+$70.2K |
| 5 |
Jane Street
New York
|
+$45.5K |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$491K |
| 2 |
BlackRock
New York
|
-$247K |
| 3 |
Millennium Management
New York
|
-$119K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$79.5K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$47.6K |
